Related references
Note: Only part of the references are listed.Rho GTPase signaling complexes in cell migration and invasion
Campbell D. Lawson et al.
JOURNAL OF CELL BIOLOGY (2018)
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
Sabine Hombach-Klonisch et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Rho GTPases: Anti- or pro-neoplastic targets?
I. Zandvakili et al.
ONCOGENE (2017)
The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines
Yung-Lung Chang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2017)
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)
Michael J. Seckl et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Dovitinib enhances temozolomide efficacy in glioblastoma cells
Thatchawan Thanasupawat et al.
MOLECULAR ONCOLOGY (2017)
Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells
Javad Alizadeh et al.
SCIENTIFIC REPORTS (2017)
The Rac GTPase in Cancer: From Old Concepts to New Paradigms
Marcelo G. Kazanietz et al.
CANCER RESEARCH (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling
Peng Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial
Emma H. Allott et al.
CANCER PREVENTION RESEARCH (2017)
The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways
Masanobu Tsubaki et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
Andy J. Minn et al.
CELL (2016)
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Wirginia Likus et al.
DRUG RESISTANCE UPDATES (2016)
A Randomized Controlled Open-Label Pilot Study of Simvastatin Addition to Whole-Brain Radiation Therapy in Patients With Brain Metastases
Manal El-Hamamsy et al.
ONCOLOGY RESEARCH (2016)
Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation
Hyun Joo Jang et al.
ONCOLOGY LETTERS (2016)
ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis
Jessica L. Weatherbee et al.
ONCOTARGET (2016)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Statins are potential anticancerous agents (Review)
Abdullah K. Altwairgi
ONCOLOGY REPORTS (2015)
The effect of statins on cancer cells-review
Lucyna Matusewicz et al.
TUMOR BIOLOGY (2015)
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
P. Jiang et al.
BRITISH JOURNAL OF CANCER (2014)
Statin use and survival following glioblastoma multiforme
David Gaist et al.
CANCER EPIDEMIOLOGY (2014)
Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
Kanjoormana A. Manu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease
Behzad Yeganeh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells
Bora Oh et al.
ANTI-CANCER DRUGS (2013)
Use of statins and risk of glioma: a nationwide case-control study in Denmark
D. Gaist et al.
BRITISH JOURNAL OF CANCER (2013)
Statin Therapy Is Associated With Improved Pathologic Response to Neoadjuvant Chemoradiation in Rectal Cancer
Adam G. Mace et al.
DISEASES OF THE COLON & RECTUM (2013)
Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression
Yi Yongjun et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases
Y. Zhu et al.
CELL DEATH & DISEASE (2013)
Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo
H. Liu et al.
NEOPLASMA (2013)
Statins and Protein Prenylation in Cancer Cell Biology and Therapy
Carmen Garcia-Ruiz et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Telomere/Telomerase System: A New Target of Statins Pleiotropic Effect?
Fabiola Olivieri et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression
Carmine Spampanato et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts
S. Ghavami et al.
CELL DEATH & DISEASE (2012)
A Phase 2 Study of Irinotecan, Cisplatin, and Simvastatin for Untreated Extensive-disease Small Cell Lung Cancer
Ji-Youn Han et al.
CANCER (2011)
Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells
Jorge Humberto Tapia-Perez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Statin-induced apoptosis via the suppression of ERK1/2 and Akt activation by inhibition of the geranylgeranyl-pyrophosphate biosynthesis in glioblastoma
Masashi Yanae et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Anticancer Efficacy of Simvastatin on Prostate Cancer Cells and Tumor Xenografts Is Associated with Inhibition of Akt and Reduced Prostate-Specific Antigen Expression
Samith T. Kochuparambil et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The Danish Cancer Registry
Marianne Lundkjaer Gjerstorff
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
Anna Martirosyan et al.
BMC CANCER (2010)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro
Jacek Bil et al.
CANCER LETTERS (2010)
Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
Nayana Ghosh-Choudhury et al.
CELLULAR SIGNALLING (2010)
Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition
Wen-bin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Statins and cancer risk
Igor Karp et al.
AMERICAN JOURNAL OF MEDICINE (2008)
In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia
Anthony Calabro et al.
ANTI-CANCER DRUGS (2008)
Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium
Melissa L. Bondy et al.
CANCER (2008)
Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins
Griselda Herrero-Martin et al.
FEBS LETTERS (2008)
Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status
Catia Cemeus et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Chao-Yung Wang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs
Emilie Roudier et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells
Umasundari Sivaprasad et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Anti-cancer therapy: Targeting the mevalonate pathway
KM Swanson et al.
CURRENT CANCER DRUG TARGETS (2006)
Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling
UK Khanzada et al.
ONCOGENE (2006)
Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein
S Matzno et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Mechanisms of statin-mediated inhibition of small G-protein function
A Cordle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo
KA Lewis et al.
LEUKEMIA RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix
JJ Knox et al.
EUROPEAN JOURNAL OF CANCER (2005)
C-reactive protein levels and outcomes after statin therapy
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reduction in cardiovascular events after vascular surgery with atorvastatin: A randomized trial
AES Durazzo et al.
JOURNAL OF VASCULAR SURGERY (2004)
Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery
MD Kertai et al.
AMERICAN JOURNAL OF MEDICINE (2004)
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis
A Horiguchi et al.
CLINICAL CANCER RESEARCH (2004)
Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery
PK Lindenauer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Usefulness of strain drugs in protecting against atrial fibrillation in patients with coronary artery disease
YN Young-Xu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression
DL Stirewalt et al.
LEUKEMIA RESEARCH (2003)
Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism
W Feleszko et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells
HG Farina et al.
CLINICAL & EXPERIMENTAL METASTASIS (2002)
Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma
WS Kim et al.
INVESTIGATIONAL NEW DRUGS (2001)
Share Paper
